Catch up on the top radiology content of the past week.
|Articles|April 11, 2001
ADAC taps new CEO
Philips Medical Systems has appointed Gary Burbach chief executive officer of ADAC Laboratories. ADAC, a vendor of nuclear medicine equipment and radiation therapy planning systems, was acquired by Philips in December 2000. Prior to the acquisition,
Advertisement
Philips Medical Systems has appointed Gary Burbach chief executive officer of ADAC Laboratories. ADAC, a vendor of nuclear medicine equipment and radiation therapy planning systems, was acquired by Philips in December 2000. Prior to the acquisition, Burbach served as ADAC president and COO. In his role as CEO, Burbach will be responsible for ADAC global operations, reporting to Tim Mickelson, executive vice president of Philips Medical Systems and CEO of ATL Ultrasound.
Advertisement
Related to this article
While a new article raises provocative questions about the capability of photon-counting CT (PCCT) to perhaps replace diagnostic ICA, the real revolution with this modality is going beyond stenosis measurement to a renewed focus on the disease of atherosclerosis.
The use of adjunctive CT bone reading software in women with breast cancer detected between 8 to 22 percent more metastatic lesions for reviewing radiologists and reduced CT interpretation time by 50 percent or more, according to a new study.
Catch up on the top radiology content of the past week.
Catch up on the top radiology content of the past week.
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears First MRI-Derived AI Software for Assessing Breast Cancer Recurrence Risk
2
What a Large Prostate MRI Study Reveals About AI and Unassisted Radiologist Assessment
3
Diagnostic Imaging's Weekly Scan: October 11 — October 17
4
How Photon-Counting CT Helps Us Recognize that Coronary Stenosis is Just One Piece of the Puzzle
5